21 tracked 13F filers disclose a position in PMN as of the latest SEC 13F filings, a combined $63.7M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | JANUS HENDERSON GROUP PLC | $16.4M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 2 | Deep Track Capital, LP | $10.6M | 836K | ▲New +836K sh | Q1 2026 | |
| 3 | Trails Edge Capital Partners, LP | $7.3M | 557K | —Held | Q2 2026 | |
| 4 | Ally Bridge Group (NY) LLC | $5.3M | 414K | ▲+66% Added · +165K sh | Q1 2026 | |
| 5 | Woodline Partners LP | $5.0M | 395K | ▲New +395K sh | Q1 2026 | |
| 6 | GREAT POINT PARTNERS LLC | $4.7M | 371K | ▲New +371K sh | Q1 2026 | |
| 7 | SPHERA FUNDS MANAGEMENT LTD. | $4.1M | 326K | ▲28× Added · +314K sh | Q1 2026 | |
| 8 | Squadron Capital Management LLC | $4.1M | 325K | ▲New +325K sh | Q1 2026 | |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.8M | 139K | ▲New +139K sh | Q1 2026 | |
| 10 | ADAR1 Capital Management, LLC | $1.2M | 95K | ▲New +95K sh | Q1 2026 | |
| 11 | 683 Capital Management, LLC | $1.2M | 93K | ▲New +93K sh | Q1 2026 | |
| 12 | MILLENNIUM MANAGEMENT LLC | $990K | 78K | ▲New +78K sh | Q1 2026 | |
| 13 | Ikarian Capital, LLC | $699K | 55K | ▲New +55K sh | Q1 2026 | |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | $204K | 16K | ▲New +16K sh | Q1 2026 | |
| 15 | UBS Group AG | $17K | 1K | ▼−10% Reduced · −150 sh | Q1 2026 | |
| 16 | OSAIC HOLDINGS, INC. | $5K | 360 | —Held | Q1 2026 | |
| 17 | ROYAL BANK OF CANADA | $4K | 268 | ▲+23% Added · +50 sh | Q1 2026 | |
| 18 | Steward Partners Investment Advisory, LLC | $1K | 94 | ▼−6.0% Reduced · −6 sh | Q2 2026 | |
| 19 | Federation des caisses Desjardins du Quebec | $127 | 10 | ▼−97% Reduced · −320 sh | Q1 2026 | |
| 20 | TD Waterhouse Canada Inc. | $66 | 5 | —Held | Q2 2026 | |
| 21 | Caitong International Asset Management Co., Ltd | $39 | 3 | ▲New +3 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 12 funds opened a new position in PMN and 2 added to an existing one, while 0 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MAZE THERAPEUTICS INCMAZE | 11 funds | $280.4M |
| RELMADA THERAPEUTICS INCRLMD | 11 funds | $233.4M |
| ELI LILLY & COLLY | 10 funds | $5.4B |
| TENAX THERAPEUTICS INCTENX | 10 funds | $84.4M |
| WAVE LIFE SCIENCES LTDWVE | 10 funds | $59.0M |
| REVOLUTION MEDICINES INCRVMD | 9 funds | $1.9B |
| VAXCYTE INCPCVX | 9 funds | $1.4B |
| BRIDGEBIO PHARMA INCBBIO | 9 funds | $1.2B |
| TANGO THERAPEUTICS INCTNGX | 9 funds | $572.1M |
| ABIVAX SA-ADRABVX | 9 funds | $467.6M |
| COGENT BIOSCIENCES INCCOGT | 9 funds | $425.1M |
| NUVALENT INC-ANUVL | 9 funds | $412.9M |
Ranked by how many of PMN's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Kaplan Johanne | Chief Development Officer | Buy (P) | 2K | $30K |
| Apr 22, 2026 | Kirwin Patrick D. | Director | Buy (P) | 4K | $45K |
| Mar 5, 2026 | Williams Eugene | Director | Buy (P) | 2K | $49K |
| Mar 4, 2026 | Williams Eugene | Director | Buy (P) | 2K | $48K |
| Mar 3, 2026 | Williams Eugene | Director | Buy (P) | 1K | $22K |
| Mar 2, 2026 | Williams Eugene | Director | Buy (P) | 1K | $23K |
| Feb 19, 2026 | Kaplan Johanne | Chief Development Officer | Buy (P) | 2K | $25K |
| Feb 3, 2026 | Yu Fan | 10% Owner | Buy (P) | 701K | $8.5M |
| Oct 3, 2025 | Milbury Max A. | Insider | Buy (P) | 30K | $15K |
| Jun 30, 2025 | GORDON MICHAEL S | 10% Owner | Sell (S) | 93K | — |
| Feb 10, 2025 | Cashman Neil | Chief Scientific Officer, Director | Buy (P) | 15K | $15K |
| Sep 24, 2024 | Shafmaster Madge K. | Director | Buy (P) | 70K | $91K |
Connected entities for PMN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PMN/capital-change-brief"
Use Arkolith's capital_change_brief for PMN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PMN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.